Edward Lanphier was named to the newly created position ofexecutive vice president of commercial development at SomatixTherapy Corp. of Alameda, Calif. Lanphier was senior vicepresident of business development and marketing at CeltrixPharmaceuticals Inc., and the former CEO of BioGrowth Inc.,which merged with Celtrix. Lanphier previously held positionswith Biotherapeutics Inc., Synergen Inc. and Eli Lilly & Co.Somatix is developing potential treatments based on thegenetic modification of selected human cells to enable theproduction of therapeutic substances within the body.

(c) 1997 American Health Consultants. All rights reserved.